ATELLICA IM ANTÍGENO DEL CORE HEPATITIS B (AHBCM) - COFEPRIS Registration 609R2019 SSA
Access comprehensive regulatory information for ATELLICA IM ANTÍGENO DEL CORE HEPATITIS B (AHBCM) (ATELLICA IM CORE HEPATITIS B ANTIGEN (AHBCM)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 609R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on March 26, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ATELLICA™ IM HEPATITIS B CORE ANTIGEN (AHBCM) ESTÁ PREVISTO PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUALITATIVA DE RESPUESTA AL IGM PARA EL ANTÍGENO DEL CORE DEL VIRUS DE LA HEPATITIS B (HBC IGM) EN SUERO Y PLASMA HUMANOS (EDTA, HEPARI
THE ATELLICA™ IM HEPATITIS B CORE ANTIGEN (AHBCM) ASSAY IS INTENDED FOR IN VITRO DIAGNOSTIC USE IN THE QUALITATIVE DETERMINATION OF IGM RESPONSE FOR HEPATITIS B VIRUS CORE ANTIGEN (HBC IGM) IN HUMAN SERUM AND PLASMA (EDTA, HEPARI